Insufficient scRNA-seq data for expression of CYB5RL at single-cell level.
Insufficient scRNA-seq data for expression of CYB5RL at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 99% | 408.71 | 2628 / 2642 | 99% | 3.80 | 700 / 705 |
ovary | 100% | 748.20 | 180 / 180 | 97% | 3.08 | 419 / 430 |
skin | 100% | 573.80 | 1806 / 1809 | 97% | 4.52 | 459 / 472 |
intestine | 100% | 605.49 | 965 / 966 | 97% | 3.16 | 511 / 527 |
breast | 100% | 574.12 | 459 / 459 | 96% | 3.39 | 1076 / 1118 |
stomach | 100% | 601.08 | 359 / 359 | 96% | 3.31 | 275 / 286 |
prostate | 100% | 661.23 | 245 / 245 | 96% | 2.97 | 482 / 502 |
esophagus | 100% | 480.98 | 1444 / 1445 | 92% | 3.02 | 168 / 183 |
lung | 99% | 484.15 | 572 / 578 | 92% | 2.49 | 1063 / 1155 |
kidney | 99% | 507.28 | 88 / 89 | 91% | 2.62 | 816 / 901 |
thymus | 100% | 624.50 | 653 / 653 | 86% | 1.91 | 523 / 605 |
uterus | 100% | 673.79 | 170 / 170 | 86% | 2.90 | 395 / 459 |
pancreas | 100% | 658.35 | 328 / 328 | 85% | 1.95 | 152 / 178 |
adrenal gland | 100% | 1145.52 | 258 / 258 | 81% | 2.15 | 187 / 230 |
bladder | 100% | 510.62 | 21 / 21 | 76% | 2.01 | 382 / 504 |
liver | 97% | 382.62 | 219 / 226 | 57% | 1.34 | 232 / 406 |
adipose | 100% | 543.07 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 883.61 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 512.26 | 1334 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 363.29 | 795 / 803 | 0% | 0 | 0 / 0 |
heart | 96% | 314.55 | 829 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 91% | 3.67 | 41 / 45 |
eye | 0% | 0 | 0 / 0 | 89% | 2.46 | 71 / 80 |
lymph node | 0% | 0 | 0 / 0 | 83% | 2.30 | 24 / 29 |
peripheral blood | 61% | 309.54 | 563 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0015701 | Biological process | bicarbonate transport |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0004128 | Molecular function | cytochrome-b5 reductase activity, acting on NAD(P)H |
Gene name | CYB5RL |
Protein name | cytochrome-b5 reductase (EC 1.6.2.2) NADH-cytochrome b5 reductase-like (EC 1.6.2.2) Cytochrome b5 reductase like |
Synonyms | |
Description | FUNCTION: NADH-cytochrome b5 reductases are involved in desaturation and elongation of fatty acids, cholesterol biosynthesis, drug metabolism, and, in erythrocyte, methemoglobin reduction. . |
Accessions | ENST00000497820.1 ENST00000493530.2 ENST00000311841.7 E9PL89 F8VW03 F8WDU4 E9PMD3 ENST00000421415.5 ENST00000420054.5 ENST00000528287.5 ENST00000287899.13 [Q6IPT4-4] ENST00000534324.6 [Q6IPT4-1] Q6IPT4 H0YDY7 |